MOTC (Metabolic Optimized T-Cells)

About Orgenesis

Orgenesis Inc. is on a mission to democratize access to cell and gene therapies by decentralizing their manufacturing. The company has developed the integrated POCare Platform, which combines a pipeline of therapeutic programs, validated automated processing technologies, and a global network of hospital partners to enable local production at the point of care. This strategy seeks to drastically reduce costs, simplify logistics, and accelerate the delivery of personalized therapies to patients worldwide, positioning Orgenesis as a unique enabler in the CGT ecosystem.

Therapeutic Areas